主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
KRRO
#3223
Korro Bio, Inc. Common Stock
12.130
0
+4.39%
版块:
基础:
利润货币:
日范围
年范围
日变化
+4.39%
每月变动
+6.22%
6个月变化
-68.82%
年变化
-68.82%
前一天收盘价
11.620
0
Open
12.130
0
Bid
Ask
Low
12.130
0
High
12.130
0
交易量
27
市场
股票
医疗保健
KRRO
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
9.37 M
9.39 M
9.39 M
9.39 M
9.42 M
—
Valuation ratios
Enterprise value
249.88 M
301.79 M
99.34 M
83.68 M
426.84 M
911.66 M
Price to earnings ratio
0.24
-4.06
-1.85
-1.28
-5.1
-12.29
Price to sales ratio
—
149.54
—
—
60.02
—
Price to cash flow ratio
1.68
5.65
2.56
1.73
6.54
16.48
Price to book ratio
0.06
0.49
0.06
0.04
0.15
0.74
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.09
0.09
0.12
0.14
0.11
0.46
Return on equity %
0.12
0.13
0.17
0.22
0.18
0.71
Return on invested capital %
-102.59
-71.83
-81.21
-127.88
-99.97
-380.89
Gross margin %
—
100
100
100
100
400
Operating margin %
—
-1 014.53
-981.18
-1 863.15
-1 764.86
-5 623.72
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
933.47
917.14
1 765.07
1 656.97
5 272.64
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
11.23
8.79
9.41
5.98
6.71
30.89
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
0.01
0.01
0.01
0.01
0.04
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
1.83
0.84
2.61
2.05
1.83
7.32
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
15.62
6.24
12.25
10.27
9.85
38.6
Net current asset value per share
17.42
14.74
12.92
10.93
10.46
49.06
Tangible book value per share
76.43
77.72
76.61
79.53
81.65
315.52
Working capital per share
15.87
13.07
11.55
9.1
8.9
42.62
Book value per share
76.43
77.72
76.61
79.53
81.65
315.52
新闻
Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates
Clear Street因高氨血症项目潜力上调Korro Bio股票评级
Clear Street upgrades Korro Bio stock rating on hyperammonemia program potential
Strength Seen in Korro Bio, Inc. (KRRO): Can Its 13.9% Jump Turn into More Strength?
H.C. Wainwright将Korro Bio股票评级上调至"买入",看好新药潜力
Korro Bio stock rating upgraded by H.C. Wainwright to Buy on new drug potential
派珀·桑德勒上调Korro Bio评级至增持,看好UCD疗法
Piper Sandler upgrades Korro Bio stock rating to Overweight on UCD treatment
Chardan Capital upgrades Korro Bio stock to Buy on KRRO-121 potential
Korro Bio, Inc. (KRRO) Analyst/Investor Day - Slideshow (NASDAQ:KRRO) 2026-01-28
William Blair重申Korro Bio股票市场表现评级
雷蒙德詹姆斯维持Korro Bio股票"市场表现"评级